Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.

Cheng, K; Smyth, R L; Govan, J R; Doherty, C; Winstanley, C; Denning, N; Heaf, D P; van Saene, H; Hart, C A

Cheng, K; Smyth, R L; Govan, J R; Doherty, C; Winstanley, C; Denning, N; Heaf, D P; van Saene, H; Hart, C A.

Affiliation

Cheng K; Department of Child Health, University of Liverpool, UK.

Lancet ; 348(9028): 639-42, 1996 Sep 07.

Article in En | MEDLINE | ID: mdl-8782753

Subject(s)

Anti-Bacterial Agents/antagonists & inhibitors; Cross Infection/microbiology; Cystic Fibrosis/complications; Pseudomonas Infections/microbiology; Pseudomonas aeruginosa/drug effects; Adolescent; Child; Child, Preschool; Cross Infection/transmission; Cystic Fibrosis/microbiology; DNA Fingerprinting/methods; Drug Resistance, Microbial; Genotype; Humans; Infant; Prospective Studies; Pseudomonas Infections/transmission; Pseudomonas aeruginosa/genetics; Pseudomonas aeruginosa/isolation & purification; Retrospective Studies; Sputum/microbiology; beta-Lactams

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pseudomonas aeruginosa / Pseudomonas Infections / Cross Infection / Cystic Fibrosis / Anti-Bacterial Agents Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Child / Child, preschool / Humans / Infant Language: En Journal: Lancet Year: 1996 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links